Cargando…
Discovery of 5,7-Dimethoxy-2-(3,4,5-trimethoxyphenoxy)-chromen-4-one with Lipid Lowering Effects in Hepatocytes
The population with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is increasing. However, no medicine is indicated for treating these diseases clinically nowadays. Therefore, there is an urgent need to develop a new drug to overcome NAFLD and NASH. Capillarisin, a...
Autores principales: | Chang, Yi-Han, Yen, Chia-Hung, Lai, Chih-Chung, Lai, Hsuan-Yu, Hung, Hsin-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032471/ https://www.ncbi.nlm.nih.gov/pubmed/35455445 http://dx.doi.org/10.3390/ph15040449 |
Ejemplares similares
-
5,7-Dimethoxy-2-phenyl-4H-chromen-4-one
por: Nallasivam, Angannan, et al.
Publicado: (2009) -
Modulation of Cyclins, p53 and Mitogen-Activated Protein Kinases Signaling in Breast Cancer Cell Lines by 4-(3,4,5-Trimethoxyphenoxy)benzoic Acid
por: Lee, Kuan-Han, et al.
Publicado: (2014) -
8-Iodo-5,7-dimethoxy-4-methyl-2H-chromen-2-one
por: Pereira Silva, P. S., et al.
Publicado: (2011) -
2-(5,7-Dimethoxy-4-oxo-4H-chromen-2-yl)phenyl 4-toluenesulfonate
por: Ramachandran, G., et al.
Publicado: (2008) -
5,7-Dihydroxy-3,6-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one monohydrate
por: Mohammad, Akhtar, et al.
Publicado: (2010)